Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate on Rembrandt

This article was originally published in The Tan Sheet

Executive Summary

Gillette's recent acquisition of Rembrandt toothpaste "doesn't have a meaningful impact on a worldwide basis or even on a U.S. basis, on P&G or on us," Colgate-Palmolive CEO Reuben Mark said during the company's 2003 year-end earnings call March 31. "I don't mean to brush it off, but obviously a lot of people have looked at [the brand]," Mark added. "We looked at it a number of times years ago and certainly not this time." The exec predicted potential growth in the tooth whitening segment following Gillette's expanded promotional efforts for Rembrandt products. Gillette announced its plans to buy the brand in March (1"The Tan Sheet" March 29, 2004, p. 9)...

You may also be interested in...



Gillette Enters Tooth Whitening Market With Rembrandt Acquisition

Gillette will leverage its strong international sales force to expand distribution of the Rembrandt tooth whitening line after acquiring the brand from privately held Den-Mat Corp

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel